COMBINATORIAL BLOCKADE OF DE NOVO CHOLESTEROL BIOSYNTHESIS AND PCSK9 AS A SYNERGISTIC THERAPY FRO KRAS-MUTANT COLORECTAL CANCER

被引：0
|
作者：
Wong, Chi Chun
Xu, Jiaying
Li, Weilin
Kang, Wei
To, Ka Fai
Sung, Joseph J.
Yu, Jun
机构：
来源：
GASTROENTEROLOGY | 2019年 / 156卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Sa2009
引用
收藏
页码：S470 / S471
页数：2
相关论文
共 15 条
  • [1] PCSK9 IS A THERAPEUTIC TARGET IN KRAS-MUTANT COLORECTAL CANCER
    Wong, Chi Chun
    Wu, Jianlin
    Chan, Lam-Shing
    Ji, Fenfen
    Kang, Wei
    To, Ka Fai
    Sung, Joseph J.
    Yu, Jun
    [J]. GASTROENTEROLOGY, 2021, 160 (06) : S64 - S64
  • [2] The cholesterol uptake regulator PCSK9 promotes and is a therapeutic target in APC/KRAS-mutant colorectal cancer
    Chi Chun Wong
    Jian-Lin Wu
    Fenfen Ji
    Wei Kang
    Xiqing Bian
    Huarong Chen
    Lam-Shing Chan
    Simson Tsz Yat Luk
    Samuel Tong
    Jiaying Xu
    Qiming Zhou
    Dabin Liu
    Hao Su
    Hongyan Gou
    Alvin Ho-Kwan Cheung
    Ka Fai To
    Zongwei Cai
    Jerry W. Shay
    Jun Yu
    [J]. Nature Communications, 13
  • [3] The cholesterol uptake regulator PCSK9 promotes and is a therapeutic target in APC/KRAS-mutant colorectal cancer
    Wong, Chi Chun
    Wu, Jian-Lin
    Ji, Fenfen
    Kang, Wei
    Bian, Xiqing
    Chen, Huarong
    Chan, Lam-Shing
    Luk, Simson Tsz Yat
    Tong, Samuel
    Xu, Jiaying
    Zhou, Qiming
    Liu, Dabin
    Su, Hao
    Gou, Hongyan
    Cheung, Alvin Ho-Kwan
    To, Ka Fai
    Cai, Zongwei
    Shay, Jerry W.
    Yu, Jun
    [J]. NATURE COMMUNICATIONS, 2022, 13 (01)
  • [4] Dual blockade of macropinocytosis and asparagine bioavailability shows synergistic anti-tumor effects on KRAS-mutant colorectal cancer
    Hanada, Keita
    Kawada, Kenji
    Nishikawa, Gen
    Toda, Kosuke
    Maekawa, Hisatsugu
    Nishikawa, Yasuyo
    Masui, Hideyuki
    Hirata, Wataru
    Okamoto, Michio
    Kiyasu, Yoshiyuki
    Honma, Shusaku
    Ogawa, Ryotaro
    Mizuno, Rei
    Itatani, Yoshiro
    Miyoshi, Hiroyuki
    Sasazuki, Takehiko
    Shirasawa, Senji
    Taketo, M. Mark
    Obama, Kazutaka
    Sakai, Yoshiharu
    [J]. CANCER LETTERS, 2021, 522 : 129 - 141
  • [5] Targeting de novo lipogenesis and the Lands cycle induces ferroptosis in KRAS-mutant lung cancer
    Caterina Bartolacci
    Cristina Andreani
    Gonçalo Vale
    Stefano Berto
    Margherita Melegari
    Anna Colleen Crouch
    Dodge L. Baluya
    George Kemble
    Kurt Hodges
    Jacqueline Starrett
    Katerina Politi
    Sandra L. Starnes
    Daniele Lorenzini
    Maria Gabriela Raso
    Luisa M. Solis Soto
    Carmen Behrens
    Humam Kadara
    Boning Gao
    Ignacio I. Wistuba
    John D. Minna
    Jeffrey G. McDonald
    Pier Paolo Scaglioni
    [J]. Nature Communications, 13
  • [6] SLC25A22 Is Essential for Supporting Aspartate Biosynthesis and Is a Specific Vulnerability in KRAS-Mutant Colorectal Cancer
    Wong, Chi Chun
    Li, Xiaona
    Qian, Yun
    Xu, Jiaying
    Kang, Wei
    To, Ka Fai
    Sung, Joseph
    Cai, Zongwei
    Yu, Jun
    [J]. GASTROENTEROLOGY, 2016, 150 (04) : S139 - S139
  • [7] Targeting de novo lipogenesis and the Lands cycle induces ferroptosis in KRAS-mutant lung cancer (vol 13, 4327, 2022)
    Bartolacci, Caterina
    Andreani, Cristina
    Vale, Goncalo
    Berto, Stefano
    Melegari, Margherita
    Crouch, Anna Colleen
    Baluya, Dodge L.
    Kemble, George
    Hodges, Kurt
    Starrett, Jacqueline
    Politi, Katerina
    Starnes, Sandra L.
    Lorenzini, Daniele
    Raso, Maria Gabriela
    Solis Soto, Luisa M.
    Behrens, Carmen
    Kadara, Humam
    Gao, Boning
    Wistuba, Ignacio I.
    Minna, John D.
    McDonald, Jeffrey G.
    Scaglioni, Pier Paolo
    [J]. NATURE COMMUNICATIONS, 2022, 13 (01)
  • [8] Inhibition of pcsk9 impairs the development of vessel co- option and potentiates antiangiogenic therapy in colorectal cancer liver metastases
    Rada, Miran
    Krzywon, Lucyna
    Kapelanski-Lamoureux, Audrey
    Petrillo, Stephanie
    Reynolds, Andrew
    Lazaris, Anthoula
    Seidah, Nabil
    Metrakos, Peter
    [J]. CANCER RESEARCH, 2023, 83 (07)
  • [9] A dual gene combination therapy approach by KRAS-G12V gene editing and SLC25A22 gene silencing for KRAS-mutant colorectal cancer
    Jin, Jiaying
    Li, Yijia
    Deng, Feiyang
    Yang, Long
    Lin, Yuxing
    Yang, Canyu
    Dai, Wenbing
    Zhang, Hua
    He, Bing
    Zhang, Qiang
    Wang, Xueqing
    [J]. NANO TODAY, 2024, 56
  • [10] LKB1 loss is a novel genomic predictor of de novo resistance to PD-1/PD-L1 axis blockade in KRAS-mutant lung adenocarcinoma
    Skoulidis, F.
    Hellman, M. D.
    Awad, M.
    Gainor, J. F.
    Rizvi, H.
    Carter, B.
    Denning, W. L.
    Villalobos, P.
    Parra, E. R.
    Elamin, Y. Y.
    Zhang, J.
    Leonardi, G. C.
    Halpenny, D. F.
    Papadimitrakopoulou, V.
    Wistuba, I. I.
    Wolchok, J. D.
    Shaw, A. T.
    Janne, P. A.
    Rudin, C. M.
    Heymach, J. V.
    [J]. ANNALS OF ONCOLOGY, 2017, 28
12